Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  rhizoxin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-9 of 9 for your search:
Start Over
Phase II Trial of Rhizoxin in Patients with Advanced Ovarian Cancer (Summary Last Modified 12/92)
Phase: Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: CRC-PHASE-II-PH2/024
Phase II Trial of Rhizoxin in Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 09/92)
Phase: Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: CRC-PHASE-II-PH2/025
Phase II Trial of Rhizoxin in Patients with Advanced Colorectal Cancer (Summary Last Modified 12/92)
Phase: Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: CRC-PHASE-II-PH2/023
Phase II Study of Rhizoxin in Patients with Advanced Nonsmall Cell Lung Cancer (Summary Last Modified 11/93)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: EORTC-16912N
Phase II Study of Rhizoxin in Patients with Advanced Malignant Melanoma (Summary Last Modified 09/93)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: EORTC-16912M
Phase II Study of Rhizoxin in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 09/93)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: EORTC-16912H
Phase II Study of Rhizoxin in Patients with Advanced Breast Cancer (Summary Last Modified 09/93)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: EORTC-16912B
Phase I Study of Rhizoxin Administered as a 72-Hour Continuous Infusion with or without G-CSF for Malignant Solid Tumors Including Lymphomas (Summary Last Modified 05/98)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-7265, NCI-T94-0004H, T94-0004
Phase I Study of Rhizoxin Administered as a 72-Hour Continuous Infusion Every 21 Days for Advanced Malignancies (Summary Last Modified 11/98)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UTHSC-9345011494, NCI-T94-0124D, T94-0124
Start Over